These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 27023460

  • 1. Effects of the Chinese herbal formula "Zuojin Pill" on the pharmacokinetics of dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype.
    Qiu F, Liu S, Miao P, Zeng J, Zhu L, Zhao T, Ye Y, Jiang J.
    Eur J Clin Pharmacol; 2016 Jun; 72(6):689-95. PubMed ID: 27023460
    [Abstract] [Full Text] [Related]

  • 2. Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan.
    Abduljalil K, Frank D, Gaedigk A, Klaassen T, Tomalik-Scharte D, Jetter A, Jaehde U, Kirchheiner J, Fuhr U.
    Clin Pharmacol Ther; 2010 Nov; 88(5):643-51. PubMed ID: 20881950
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of Zuojin Pill on the Metabolism of Venlafaxine in Vitro and in Rats and Associated Herb-Drug Interaction.
    Li Y, Li J, Yan D, Wang Q, Jin J, Tan B, Qiu F.
    Drug Metab Dispos; 2020 Oct; 48(10):1044-1052. PubMed ID: 32561594
    [Abstract] [Full Text] [Related]

  • 5. Effects of Maribavir on P-Glycoprotein and CYP2D6 in Healthy Volunteers.
    Song IH, Ilic K, Murphy J, Lasseter K, Martin P.
    J Clin Pharmacol; 2020 Jan; 60(1):96-106. PubMed ID: 31385617
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population.
    Dorado P, Heras N, Machín E, Hernández F, Teran E, Llerena A.
    Eur J Clin Pharmacol; 2012 May; 68(5):637-44. PubMed ID: 22083166
    [Abstract] [Full Text] [Related]

  • 8. Investigation of the Differences in the Pharmacokinetics of CYP2D6 Substrates, Desipramine, and Dextromethorphan in Healthy African Subjects Carrying the Allelic Variants CYP2D6*17 and CYP2D6*29, When Compared with Normal Metabolizers.
    Marasanapalle VP, Masimirembwa C, Sivasubramanian R, Sayyed S, Weinzierl-Hinum A, Mehta D, Kapungu NN, Kanji C, Thelingwani R, Zack J.
    J Clin Pharmacol; 2024 May; 64(5):578-589. PubMed ID: 37803948
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and polymorphic oxidation of dextromethorphan in a Japanese population.
    Nagai N, Kawakubo T, Kaneko F, Ishii M, Shinohara R, Saito Y, Shimamura H, Ohnishi A, Ogata H.
    Biopharm Drug Dispos; 1996 Jul; 17(5):421-33. PubMed ID: 8830977
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphism of CYP2D6 and CYP2C19 metabolism determined by phenotyping Israeli ethnic groups.
    Britzi M, Bialer M, Arcavi L, Shachbari A, Kapitulnik T, Soback S.
    Ther Drug Monit; 2000 Oct; 22(5):510-6. PubMed ID: 11034254
    [Abstract] [Full Text] [Related]

  • 12. Effect of a traditional Chinese medicine Liu Wei Di Huang Wan on the activities of CYP2C19, CYP2D6 and CYP3A4 in healthy volunteers.
    Chen Y, Ouyang DS, Kang Z, Yang GP, Tan ZR, Zhou G, Yan J.
    Xenobiotica; 2012 Jun; 42(6):596-602. PubMed ID: 22208477
    [Abstract] [Full Text] [Related]

  • 13. Assessment of CYP2D6 and CYP2C19 activity in vivo in humans: a cocktail study with dextromethorphan and chloroguanide alone and in combination.
    Tennezé L, Verstuyft C, Becquemont L, Poirier JM, Wilkinson GR, Funck-Brentano C.
    Clin Pharmacol Ther; 1999 Dec; 66(6):582-8. PubMed ID: 10613613
    [Abstract] [Full Text] [Related]

  • 14. Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application.
    Dickinson GL, Rezaee S, Proctor NJ, Lennard MS, Tucker GT, Rostami-Hodjegan A.
    J Clin Pharmacol; 2007 Feb; 47(2):175-86. PubMed ID: 17244768
    [Abstract] [Full Text] [Related]

  • 15. Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.
    Gaedigk A, Bradford LD, Marcucci KA, Leeder JS.
    Clin Pharmacol Ther; 2002 Jul; 72(1):76-89. PubMed ID: 12152006
    [Abstract] [Full Text] [Related]

  • 16. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers.
    Aarnoutse RE, Kleinnijenhuis J, Koopmans PP, Touw DJ, Wieling J, Hekster YA, Burger DM.
    Clin Pharmacol Ther; 2005 Dec; 78(6):664-74. PubMed ID: 16338282
    [Abstract] [Full Text] [Related]

  • 17. Potential interactions of methylphenidate and atomoxetine with dextromethorphan.
    Ciccone PE, Ramabadran K, Jessen LM.
    J Am Pharm Assoc (2003); 2006 Dec; 46(4):472-8. PubMed ID: 16913391
    [Abstract] [Full Text] [Related]

  • 18. The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase, in extensive or intermediate metabolizers of CYP2D6.
    Nakao M, Muramoto Y, Hisadome M, Yamano N, Shoji M, Fukushima Y, Saruwatari J, Nakagawa K.
    Eur J Clin Pharmacol; 2007 Apr; 63(4):345-53. PubMed ID: 17297618
    [Abstract] [Full Text] [Related]

  • 19. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan.
    Kévorkian JP, Michel C, Hofmann U, Jacqz-Aigrain E, Kroemer HK, Peraldi MN, Eichelbaum M, Jaillon P, Funck-Brentano C.
    Clin Pharmacol Ther; 1996 May; 59(5):583-92. PubMed ID: 8646830
    [Abstract] [Full Text] [Related]

  • 20. Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot study.
    Zawertailo LA, Kaplan HL, Busto UE, Tyndale RF, Sellers EM.
    J Clin Psychopharmacol; 1998 Aug; 18(4):332-7. PubMed ID: 9690700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.